Twitter
Twitter
Be a member
Login
phone
+966-53-624-7718
mail
info@saudioncology.org
Events
Organizing
Main Speakers
Online Registration
Annual Conferences
Menu
HOME
ABOUT US
HISTORY
VISION
Mission
GOALS
PRESIDENT MESSAGE
BOARD MEMBERS
BRANCHES
POLICY
Registration
MEMBER
JOIN/RENEW MEMBERSHIP ONLINE
MEMBERSHIP BENEFITS
SOS LIBRARY
EVENTS AND ACTIVITIES
ELECTIONS
RESOURCES
Medical Journals
CANCER AWARENESS RIBBONS
CLINICAL TRIALS
PARTNERS & WEBSITES
CLINICAL GUIDLINES
MULTIMEDIA
Educational Video Library
EVENTS
CONTACT US
Meet The Expert:
Meet The Expert - Part 1
In this short Video, Dr. Meteb Al Foheidi from the Department of Oncology at King Saud Bin Abdulaziz University for Health Science – NGHA, Jeddah& the Chairman of board of directors of Saudi Oncology Society, & Dr Mark Verrill from Northern center for cancer care at Freeman hospital, UK discuss the Monarch 2 HR+ HER2- MBC patients’ characteristics and the OS results
Meet The Expert - Part 2
In this short Video, Dr. Meteb Al Foheidi from the Department of Oncology at King Saud Bin Abdulaziz University for Health Science – NGHA, Jeddah& the Chairman of board of directors of Saudi Oncology Society, & Dr Mark Verrill from Northern center for cancer care at Freeman hospital, UK discuss the maturity of OS data from Monarch 2 trial in HR+ HER2- MBC patients
Meet The Expert - Part 3
In this short Video, Dr. Meteb Al Foheidi from the Department of Oncology at King Saud Bin Abdulaziz University for Health Science – NGHA, Jeddah& the Chairman of board of directors of Saudi Oncology Society, & Dr Mark Verrill from Northern center for cancer care at Freeman hospital, UK discuss the clinical impact of Monarch 2 OS data on the clinical practice
Meet The Expert - Part 4
In this short Video, Dr. Meteb Al Foheidi from the Department of Oncology at King Saud Bin Abdulaziz University for Health Science – NGHA, Jeddah& the Chairman of board of directors of Saudi Oncology Society, & Dr Mark Verrill from Northern center for cancer care at Freeman hospital, UK discuss the delay of chemotherapy in the HR+ HER2- MBC patients receiving Abemaciclib plus Fulvestrant
Meet The Expert - Part 5
In this short Video, Dr. Meteb Al Foheidi from the Department of Oncology at King Saud Bin Abdulaziz University for Health Science – NGHA, Jeddah& the Chairman of board of directors of Saudi Oncology Society, & Dr Mark Verrill from Northern center for cancer care at Freeman hospital, UK discuss the safety & tolerability of Abemaciclib and patient counseling
Menu
